García-Foncillas López, J. M., Bokemeyer, C., Italiano, A., Keating, K., Paracha, N., Fellous, M., . . . Lassen, U. (2022). Indirect treatment comparison of larotrectinib versus entrectinib in treating patients with TRK gene fusion cancers.
Citación estilo ChicagoGarcía-Foncillas López, Jesús Miguel, et al. Indirect Treatment Comparison of Larotrectinib Versus Entrectinib in Treating Patients With TRK Gene Fusion Cancers. 2022.
Cita MLAGarcía-Foncillas López, Jesús Miguel, et al. Indirect Treatment Comparison of Larotrectinib Versus Entrectinib in Treating Patients With TRK Gene Fusion Cancers. 2022.
Precaución: Estas citas no son 100% exactas.